Next Biosciences is just here for the sex with MiniMi By Next Biosciences 4 December 2023 Next Biosciences' Laboratory Research and Technical Specialist, Gloudi Agenbag has developed the MiniMi Early Fetal Sex Test that allows expecting parents the choice to find out their baby’s sex from as early as 10 weeks, with an accuracy of 98%.
World Cord Blood Day: Understanding cord blood stem cells By Dr Someshni Moodley 15 November 2023 As we celebrate World Cord Blood Day, it is an opportune moment to explore the incredible value held within a simple resource: umbilical cord blood. Amidst the wonder of welcoming a newborn into the world, parents are often unaware of the lifesaving potential contained within cord blood, which are stem cells.
The truth about placental tissue storage: Is it worth it? By Dr Someshni Moodley 14 November 2023 Discover the truth about placental tissue storage. Are the benefits worth the cost? Unveiling the facts for informed family decisions.
Updated position statement from the ISPD By Next Biosciences 13 November 2023 The International Society for Prenatal Diagnosis have recently published a position statement in Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies.
Next Biosciences launches PharmaGene By Next Biosciences 24 October 2023 Next Biosciences is changing the face of medicine in the country with the launch of PharmaGene – a new pharmacogenomics test, making individualised precision medicine possible.
The food-mood connection: How dietary choices affect mood swings By Next Biosciences 9 October 2023 Research has shed light on the intricate relationship between our diets, the gut microbiome, and mood regulation. The blog post delves into the fascinating connection between dietary habits and mood swings and how you can make informed choices to support your mental health.
Enabling a more personalised approach to psychiatric treatment By Caela De Beer 3 October 2023 Psychiatry has come a long way in its understanding and treatment of mental health disorders. Gone are the days of a one-size-fits-all approach to psychiatric medication.
Newborn Screening: Genetic and metabolic disease diagnoses in South Africa By Next Biosciences 21 September 2023 In this blog post, we will delve into the landscape of genetic and metabolic disease diagnoses in South Africa, highlighting key conditions, prevalence rates, and the role of ethnicity in susceptibility.
Importance of a universal newborn screening in South Africa By Next Biosciences 18 August 2023 Newborn screening is a remarkable tool that empowers healthcare professionals to identify potential threats before they can impact a new baby’s health.
Next Biosciences' partners with Adcock Ingram By Next Biosciences 16 August 2023 Next Biosciences is thrilled to unveil its strategic partnership with Adcock Ingram as of July 2023, a renowned leader in the eye care field.